|
Empowerment for the whining peasants, aka RVX retail...but only if you want it!
|
8
|
Resverlogix Corp.
|
May 28, 2022 03:18PM
|
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
8
|
Resverlogix Corp.
|
Mar 19, 2022 04:29AM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
8
|
Resverlogix Corp.
|
May 14, 2022 02:14PM
|
|
Re: Another reason
|
8
|
Resverlogix Corp.
|
Jan 10, 2022 04:47PM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
8
|
Resverlogix Corp.
|
Sep 19, 2020 08:35PM
|
|
Re: RVX AGM 12/22/2020 - rough transcript
|
8
|
Resverlogix Corp.
|
Dec 30, 2020 08:38PM
|
|
3D Human Heart Organoids.
|
8
|
Resverlogix Corp.
|
Jun 25, 2021 06:26PM
|
|
Re: Re San fran
|
9
|
Resverlogix Corp.
|
Oct 20, 2020 03:04PM
|
|
Re: Warning: Long - Thoughts on Management
|
9
|
Resverlogix Corp.
|
Mar 24, 2021 11:05PM
|
|
Re: Covid and apabetalone
|
9
|
Resverlogix Corp.
|
Oct 21, 2020 12:04AM
|
|
Re: We have just tomorrow and Weds...
|
9
|
Resverlogix Corp.
|
Feb 01, 2021 07:57PM
|
|
Just to refresh the memories.
|
9
|
Resverlogix Corp.
|
Jan 18, 2021 06:06PM
|
|
Re: ABBV-744 is BD2 specific - worth a read
|
9
|
Resverlogix Corp.
|
Feb 02, 2022 06:07PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
9
|
Resverlogix Corp.
|
Apr 14, 2021 10:57PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
9
|
Resverlogix Corp.
|
Apr 28, 2022 12:53PM
|
|
Re: So I was able to finally set up a one on one meeting with...
|
9
|
Resverlogix Corp.
|
Mar 14, 2022 11:28AM
|
|
Re: Resverlogix warrants to be delisted June 21
|
9
|
Resverlogix Corp.
|
Jun 14, 2021 02:36PM
|
|
Re: Globe - Lessons from accelerated vaccine development - May 25, 2021
|
9
|
Resverlogix Corp.
|
May 26, 2021 06:57PM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
9
|
Resverlogix Corp.
|
Mar 18, 2022 12:38AM
|
|
Re: New Apabetalone Fabry Disease Publication
|
9
|
Resverlogix Corp.
|
Apr 27, 2022 09:57PM
|
